Transcription of Drug-induced liver injury (DILI) - CIOMS
{{id}} {{{paragraph}}}
Drug-induced liver injury (DILI): Current status and future directions for drug development and the post-market settingA consensus by a CIOMS Working GroupCouncil for International Organizations of Medical Sciences ( CIOMS )Geneva 2020 Drug-induced liver injury (DILI): Current status and future directions for drug development and the post-market settingA consensus by a CIOMS Working GroupCouncil for International Organizations of Medical Sciences ( CIOMS )Geneva 2020 Copyright 2020 by the Council for International Organizations of Medical Sciences ( CIOMS ) ISBN: 978-929036099-5 All rights reserved. CIOMS publications may be obtained directly from CIOMS through its publications e-module at Further information can be obtained from CIOMS , Box 2100, CH-1211 Geneva 2, Switzerland, tel.
MID-NET Medical Information Database Network (Japan). miR122 microRNA 122 MRCP Magnetic resonance cholangiopancreatography MRI Magnetic resonance imaging NAFLD Non-alcoholic fatty liver disease NASH Nonalcoholic steatohepatitis
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}